CNTX Context Therapeutics Inc
Company Analysis
Latest News
🟢 Context Therapeutics is trading 5% up in after-hours trading
Context Therapeutics is trading at $0.29, up 5.20% in after-hours trading; no clear company-specific catalyst was identified for the October 13 gain. - The...
🔴 Context Therapeutics is trading 10% down with no clear company-specific catalyst identified
Context Therapeutics is trading down 10.16% at $0.27 on October 13, 2026, with no clear company-specific catalyst identified. - The latest company...
🔴 Context Therapeutics is trading 6% down with no specific catalyst identified
Context Therapeutics is trading 6.03% lower at $0.29 on October 13, 2026, with no specific company catalyst identified. - The latest listed company release...
🔴 Context Therapeutics is trading 7.63% down in pre-market
Context Therapeutics is trading at $0.28, down 7.63% in pre-market, with no clear overnight company-specific catalyst identified. - The company’s...
🔴 Context Therapeutics is trading 5% down amid biotech-sector weakness
Context Therapeutics is trading 5.02% lower at $0.30 on October 8, 2026, alongside biotech-sector weakness and broader market pressure; no company-specific...
🔴 Context Therapeutics is trading 5% down with no clear company-specific catalyst identified
Context Therapeutics is trading 5.02% down at $0.32, with no clear company-specific announcement identified to explain the October 6, 2026 move. - The latest...
🟢 Context Therapeutics is trading 7% up with no clear company-specific catalyst
Context Therapeutics is trading at $0.36, up 6.98%, with no clear company-specific catalyst identified for October 6. - The company’s press-release page lists...
🟢 Context Therapeutics is trading 5% up
Context Therapeutics is trading up 5.17% at $0.33 as of 9:48 a.m. ET on October 5, 2026, with no clear company-specific catalyst identified. - The company’s...
🟢 Context Therapeutics is trading 5% up today — no clear catalyst identified
Context Therapeutics is trading at $0.32, up 5.33% on October 1, with no clear company-specific catalyst identified. - The gain follows six consecutive...
🟢 Context Therapeutics is trading 6.5% up in pre-market, with no clear company-specific catalyst identified
Context Therapeutics is trading 6.5% higher at $0.32 in pre-market on October 1, 2026, with no clear company-specific catalyst identified. - Shares closed at...
🟢 Context Therapeutics is trading 6.5% up in after-hours trading with no clear catalyst identified
Context Therapeutics is trading at $0.32, up 6.5%, after a sharp after-hours reversal following several consecutive daily declines. - Shares closed the...
🔴 Context Therapeutics is trading 5.4% down
Context Therapeutics is trading 5.4% down at $0.30, with no clear company-specific catalyst identified for the September 30, 2026 decline. - The latest...
🟢 Context Therapeutics is trading 10% up in pre-market; no clear catalyst identified
Context Therapeutics is trading at $0.35, up 9.72%, with the cause of its September 30 pre-market move unclear. - No clear company-specific catalyst was...
🔴 Context Therapeutics is trading 5.9% down; no company-specific explanation identified
Context Therapeutics is trading 5.9% lower at $0.33, with no company-specific explanation identified for the September 28 move. - The latest located company...
🟢 Context Therapeutics is trading 7% up in pre-market — no clear catalyst identified
Context Therapeutics is trading 7.03% up at $0.37 now in pre-market on September 28, 2026, with no company-specific announcement explaining the move...
🔴 Context Therapeutics is trading 5.1% down today with no clear company-specific catalyst
Context Therapeutics is trading 5.1% down at $0.35, with no clear company-specific catalyst identified. - No credible company-specific announcement dated...
🟢 Context Therapeutics rises 5.4% — Biotech Sector Rallies on Major AI Collaboration Deal and Positive Clinical News
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is trading higher, driven by a...
🟢 Context Therapeutics is trading 5.68% up today in pre-market on stronger U.S. equity futures
Context Therapeutics is trading at $0.39, up +5.68% in pre-market amid broader risk-on conditions. - No new company-specific announcement, earnings release,...
🟢 Context Therapeutics is trading 5% up in after-hours trading amid broader risk-on conditions
Context Therapeutics is trading 5.41% up at $0.39 after-hours on September 18, 2026, with the move appearing mainly aligned with broader risk-on conditions. -...
🟢 Context Therapeutics is trading 7.98% up today; immediate trigger remains unclear
Context Therapeutics is trading 7.98% up at $0.38, following a September 14 close of $0.35; the immediate trigger remains unclear. - No new company-specific...